We are live on ! Find out more
Amundi

Amundi Portfolio holdings

AUM $367B
1-Year Est. Return 31.23%
 

Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.

This Fund
S&P 500
This Quarter Est. Return
-2.89%
1 Year Est. Return
+31.23%
3 Year Est. Return
+96.94%
5 Year Est. Return
+128.55%
10 Year Est. Return
AUM
$275B
AUM Growth
-$12.9B
Cap. Flow
+$14.6B
Cap. Flow %
5.3%
Top 10 Hldgs %
27.78%
Holding
2,276
New
139
Increased
822
Reduced
1,013
Closed
84

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.39B
2
AVGO icon
Broadcom
AVGO
+$2.51B
3
NVDA icon
NVIDIA
NVDA
+$2.37B
4
MSFT icon
Microsoft
MSFT
+$1.65B
5
AMZN icon
Amazon
AMZN
+$1.58B

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.02B
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$776M
3
UNH icon
UnitedHealth
UNH
+$737M
4
MRSH
Marsh
MRSH
+$577M
5
PEP icon
PepsiCo
PEP
+$438M

Sector Composition

Rank Sector Weight
1 Technology 31.17%
2 Financials 12.48%
3 Consumer Discretionary 11.87%
4 Healthcare 11.61%
5 Communication Services 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLRX icon
2076
Pliant Therapeutics
PLRX
$67.5M
$181 ﹤0.01%
138
+86
+165% +$522
NRIX icon
2077
Nurix Therapeutics
NRIX
$2.43B
$179 ﹤0.01%
17
WOLF icon
2078
Wolfspeed
WOLF
$1.2B
$152 ﹤0.01%
56
JJSF icon
2079
J&J Snack Foods
JJSF
$1.43B
$134 ﹤0.01%
1
-3
-75% -$403
STKL
2080
DELISTED
SunOpta
STKL
$125 ﹤0.01%
28
-40
-59% -$266
PPLI
2081
People Inc
PPLI
$3.1B
$110 ﹤0.01%
4
-18
-82% -$657
ERAS icon
2082
Erasca
ERAS
$6.63B
$97 ﹤0.01%
80
-287
-78% -$493
TRDA icon
2083
Entrada Therapeutics
TRDA
$227M
$96 ﹤0.01%
12
-42
-78% -$523
TRML
2084
DELISTED
Tourmaline Bio
TRML
$92 ﹤0.01%
7
-31
-82% -$497
RLAY icon
2085
Relay Therapeutics
RLAY
$4.02B
$82 ﹤0.01%
36
-164
-82% -$643
LILAK icon
2086
Liberty Latin America Class C
LILAK
$1.5B
$79 ﹤0.01%
14
-94
-87% -$570
DXPE icon
2087
DXP Enterprises
DXPE
$2.62B
$78 ﹤0.01%
1
-8
-89% -$738
PFGC icon
2088
Performance Food Group
PFGC
$17.5B
$76 ﹤0.01%
1
-724
-100% -$60.4K
SYRE icon
2089
Spyre Therapeutics
SYRE
$8.87B
$70 ﹤0.01%
5
-27
-84% -$562
REVG
2090
DELISTED
REV Group
REVG
$59 ﹤0.01%
2
-22
-92% -$712
XMTR icon
2091
Xometry
XMTR
$4.77B
$43 ﹤0.01%
2
-21
-91% -$660
TPC
2092
Tutor Perini Cor
TPC
$4.57B
$43 ﹤0.01%
2
-24
-92% -$592
JBI icon
2093
Janus International
JBI
$722M
$40 ﹤0.01%
6
-89
-94% -$707
MRTN icon
2094
Marten Transport
MRTN
$1.33B
$40 ﹤0.01%
3
-37
-93% -$551
CNNE icon
2095
Cannae Holdings
CNNE
$647M
$36 ﹤0.01%
2
-30
-94% -$566
PWP icon
2096
Perella Weinberg Partners
PWP
$1.14B
$34 ﹤0.01%
2
-26
-93% -$590
MRC
2097
DELISTED
MRC Global
MRC
$32 ﹤0.01%
3
-48
-94% -$620
THR
2098
DELISTED
Thermon Group Holdings
THR
$26 ﹤0.01%
1
-21
-95% -$607
PHVS icon
2099
Pharvaris
PHVS
$2.39B
$15 ﹤0.01%
1
-142
-99% -$2.4K
ALGM icon
2100
Allegro MicroSystems
ALGM
$8.58B
-56,994
Closed -$1.35M

Similar funds

Amundi's Q1 2025 Portfolio in Review

As of Q1 2025, Amundi held 2,276 positions worth $275B, down 4.5% from $288B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Amundi deployed $14.6B of net new capital in Q1 2025, opening 139 new positions and adding to 822 existing holdings. Its largest new stake was APi Group: 474,780 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Qualcomm, an estimated $1.02B trimmed.

  • Amundi's largest Q1 2025 buy was APi Group: 474,780 shares worth $10.7M.
  • Amundi added most to Apple in Q1 2025, an estimated $3.39B increase.
  • Amundi's biggest Q1 2025 reduction was Qualcomm, cutting an estimated $1.02B.
  • Amundi fully exited Arcadium Lithium plc in Q1 2025, selling an estimated $59.8M.
  • Amundi's ten largest holdings make up 28% of its $275B portfolio in Q1 2025.
  • Amundi opened 139 new positions and closed 84 in Q1 2025.
  • Amundi's portfolio value fell 4.5% quarter-over-quarter to $275B.

Based on Amundi's 13F filing for Q1 2025, filed 15 May 2025.